Skip to content

Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda

Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01140633
Enrollment
46
Registered
2010-06-09
Start date
2010-04-30
Completion date
2012-08-31
Last updated
2013-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-infection/Aids

Keywords

HIV/AIDS, pediatric, wireless adherence monitoring, HIV Infections

Brief summary

Current measures of adherence detect problems weeks to months after they occur. Because the HIV virus rapidly begins replicating and mutating in the absence of effective antiretroviral therapy, treatment failure may develop before an intervention can be deployed. Real-time objective adherence monitoring could redirect efforts from a reactive response to the proactive prevention of treatment failure. Because adherence is so closely associated with viral suppression, accurate adherence monitoring could also strategically limit viral monitoring only to those patients at a defined risk for viral rebound. This observational study is assessing a wireless adherence monitoring device and mobile phone-based adherence data collection among caregivers of children under the age of ten years in Mbarara, Uganda. It involves both quantitative and qualitative measures of the feasibility and acceptability of these measures, as well as circumstances of adherence lapses and other individual and cultural factors affecting adherence. The qualitative data will be used to explore models of adherence behavior, which will likely include the child-caregiver dynamic, the child's mental and physical health, and social support mechanism.

Detailed description

See above.

Interventions

None listed

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Mbarara University of Science and Technology
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* age 1 to 10 years * HIV-infected, meeting Ugandan criteria for antiretroviral therapy * living within 30 km of Mbarara, Uganda

Exclusion criteria

* lack of mobile-phone reception

Design outcomes

Primary

MeasureTime frameDescription
Distribution of adherenceMonthly adherence levels will be determined over the six-month study period.Distribution of adherence based on wireless adherence monitoring devices and interactive voice response (IVR) or short message service (SMS) self report by caregivers of HIV-infected children under ten years old in Mbarara, Uganda.

Secondary

MeasureTime frameDescription
Feasibility and acceptability of wireless adherence measuresAssessments will be made a the one-month time point.Quantitive rating and qualitative description of the feasibility and acceptability of wireless adherence measures
Model of adherence behaviorData collected at baseline and during adherence interruptions will be analyzed at the end of the six-month study period.Qualitative data will be used to explore a theoretical model of adherence behavior among young children in a rural African setting

Countries

Uganda

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026